AS
AMED

Altshuler Shaham’s Amedisys AMED Stock Holding History

Altshuler Shaham’s Portfolio AMED Stock Details AMED Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-161
Closed -$43K – 608
2021
Q1 		$43K Buy
161
+19
+13% +$5.36K ﹤0.01% 306
2020
Q4 		$42K Buy
142
+31
+28% +$7.95K ﹤0.01% 284
2020
Q3 		$26K Buy
111
+3
+3% +$682 ﹤0.01% 298
2020
Q2 		$21K Buy
108
+25
+30% +$4.66K ﹤0.01% 255
2020
Q1 		$15K Sell
83
-1
-1% -$178 ﹤0.01% 247
2019
Q4 		$14K Buy
84
+13
+18% +$1.93K ﹤0.01% 294
2019
Q3 		$9K Buy
+71
New +$9.24K ﹤0.01% 286
2019
Q2 		– Sell
-66
Closed -$8K – 359
2019
Q1 		$8K Buy
+66
New +$8.28K ﹤0.01% 253

Other funds holding AMED

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
RP
Riverbridge Partners Minneapolis, Minnesota $3.58B AUM 4.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return

Altshuler Shaham's AMED Position: Q2 2021 in Review

Altshuler Shaham sold out of Amedisys (AMED) in Q2 2021, closing a stake of 161 shares — an estimated $43K sold.

Altshuler Shaham first reported a position in AMED in Q1 2019 and held it in 8 quarters. The position peaked at $43K in Q1 2021. 375 funds tracked by Wall St. Rank hold AMED as of Q2 2021.

  • Altshuler Shaham reported no remaining Amedisys position as of Q2 2021 after selling out during the quarter.
  • Altshuler Shaham sold 161 Amedisys shares in Q2 2021, an estimated $43K.
  • Altshuler Shaham first reported a position in Amedisys in Q1 2019 and held it in 8 quarters.
  • Altshuler Shaham's Amedisys position peaked at $43K in Q1 2021.
  • 375 funds tracked by Wall St. Rank held Amedisys as of Q2 2021.

Based on Altshuler Shaham's 13F filing for Q2 2021, filed 16 Aug 2021.